Pro Medicus Limited (PMCUF) Research
Based in Richmond, Australia, and established in 1983, Pro Medicus Limited is a leading developer and provider of cutting-edge healthcare imaging software and support services. The company caters to a diverse range of medical institutions, including hospitals and diagnostic imaging facilities, across Australia, North America, and Europe. Its comprehensive product suite features a proprietary Radiology Information System (RIS), designed for efficient practice management, which comes complete with training, installation, professional services, and ongoing post-sales support (marketed under names like Visage RIS). Additionally, Pro Medicus offers Promedicus.net, an e-health platform, and advanced healthcare imaging software that empowers radiologists and clinicians with robust visualization capabilities for 2D, 3D, and 4D medical images, alongside its Picture Archiving and Communication System (PACS)/digital imaging solutions (e.g., Visage 7). The company also provides integration products and the Visage Ease Pro mobile application, allowing users to remotely interpret diagnostic imaging studies stored on a Visage 7 server.
Market snapshot
- Symbol
- PMCUF
- Price
- $118.13
- Day change
- -0.82%
- Market cap
- $18.1B
- P/E ratio
- 76.80x
- 52-week range
- 74.52-218.25
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Next earnings
- in 2 months
- Analyst price target
- $155
Peer companies
Open Pro Medicus Limited (PMCUF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.